This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medbox, Inc. Interviewed On BBC Radio Regarding Medical Marijuana Policy

HOLLYWOOD, Calif., Jan. 9, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (, announced that a radio interview was conducted by BBC in the UK with one of the company's founders regarding medical marijuana policy as well as the company's recent stock price surge.

During the interview, which ran live at 10:20 am PST yesterday, Vincent Mehdizadeh, Founder and Senior Consultant at Medbox, Inc, commented, "As we all step back from the proverbial fiscal cliff in the US and a stagnant global economy, it's important that governments worldwide explore new tax bases that are gaining momentum. As such, Medical Marijuana should be given serious consideration as a burgeoning industry."

The company was also asked about its position on the recent outright marijuana legalizations in the US States of Washington and Colorado for recreational use. Medbox commented that while recreational legalizations appear to be gaining traction in some US jurisdictions, the company's focus remains on helping medical marijuana dispensaries operate in accordance with their states' laws. However, the company also confirmed that its technology, used behind-the-counter and at an operators' discretion, can also be utilized in retail businesses in recreational marijuana jurisdictions to assist with inventory control and accurate tax reporting.

The company was also interviewed yesterday by a Chilean journalist with "La Segunda" newspaper in Chile regarding Medbox's international aspirations as to spreading its medicine dispensing technology on a global level. The company confirmed with that reporter that 24-hour access to medical marijuana is not allowed through the company's equipment but that other solutions for after-hours prescription medication dispensing has been developed by the company for use in traditional pharmacies for access to standard medications. 

"We are pleased that Medbox is garnering so much national and international attention for our cutting-edge products and services," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "Educating the media about the differences between a "vending machine" and a "dispensing system" are a definite priority for our company."

To listen to the BBC Radio interview, simply copy and paste the link below to a web browser:

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs